Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Glaucoma. 2013 Mar;22(3):219–225. doi: 10.1097/IJG.0b013e318237c89f

Table II.

Slopes of linear regressions fitting PERG amplitude/phase and SAP-MD/PSD measurements performed during the observation period in 59 untreated glaucoma suspects.

Regression Slopes

Subjects, N=59
Mean
Slope
SD p-value
(difference
of mean
slope from
zero
+95% CI
Mean
Slope
−95% CI
Mean
Slope
Mean #
observations
per
regression
SD
OD-PERG Amplitude (% difference from normal/yr) −3.067 5.855 <0.001 −1.499 −4.635 9.5 2.6
OD PERG Phase (ms delay/year) −0.296 0.593 <0.001 −0.137 −0.455 9.5 2.6
OD SAP-MD (dB/year) 0.038 0.274 .298 0.112 −0.035 8.8 2.4
OD SAP-PSD (dB/year) −0.028 0.134 .125 0.008 −0.064 8.8 2.3
OS-PERG Amplitude (% difference from normal/yr) −1.903 4.961 .008 −0.522 −3.284 9.6 2.5
OS PERG Phase (ms delay/year) −0.409 0.548 <0.001 −0.257 −0.562 9.6 2.5
OS SAP-MD (dB/year) 0.064 0.257 .077 0.136 −0.007 8.9 2.3
OS SAP-PSD (dB/year) 0.009 0.128 .609 0.045 −0.026 8.9 2.2